Oak Associates’s St Jude Medical STJ Stock Holding History

Oak Associates’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-31,500	Closed	-$2.53M	–	174
2016 Q4	$2.53M	Hold	31,500	–	–	0.25%	87
2016 Q3	$2.45M	Hold	31,500	–	–	0.25%	86
2016 Q2	$2.46M	Hold	31,500	–	–	0.3%	80
2016 Q1	$1.73M	Sell	31,500 -800	-2%	-$43.6K	0.21%	91
2015 Q4	$2M	Buy	+32,300	New	+$2.04M	0.24%	83

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Oak Associates's STJ Position: Q1 2017 in Review

Oak Associates sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 31,500 shares — an estimated $2.53M sold.

Oak Associates first reported a position in STJ in Q4 2015 and held it in 5 quarters. The position peaked at $2.53M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Oak Associates reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Oak Associates sold 31,500 St Jude Medical shares in Q1 2017, an estimated $2.53M.
Oak Associates first reported a position in St Jude Medical in Q4 2015 and held it in 5 quarters.
Oak Associates's St Jude Medical position peaked at $2.53M in Q4 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Oak Associates's 13F filing for Q1 2017, filed 16 May 2017.